Jewish General Hospital Virtual Medical Grand Rounds

Jewish General Hospital
Department of Medicine
Monday Medical Grand Rounds
*** Noon to 1 p.m. ***

Join the virtual Medical Grand Rounds on Microsoft Teams.

Hybrid Medical Grand Rounds are additionally in person at the Block amphitheatre, room B-106

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Some Rounds were video recorded.

Medical Grand Rounds 2024-2025

April 28

(Virtual only)

The Future of Medicine

Pieter R. Cullis, PhD, FRSC, FRS, OBC, OC
Professor, Biochemistry and Molecular Biology
Faculty of Medicine
University of British Columbia

Educational Objectives:

  1. The role of proteomics in disease diagnosis
  2. The role and future of gene therapies
  3. The advancing role of personalized medicine
  4. Anti-ageing protocols

April 21

No Rounds – Easter Monday

April 14

No Rounds – Passover

April 7

What's New in Hepatitis B and D

Julian Hercun, MD
Hepatologist,
Liver Unit, CHUM
Adjunct clinical professor
Department of Medicine, Université de Montréal

Educational Objectives:

  1. Discuss the epidemiology of hepatitis B and D in Canada
  2. Recognize opportunities for screening and therapy initiation
  3. Review indications for hepatitis B prophylaxis
  4. Evaluate the potential impact of novel therapies for hepatitis B and D

March 31

Residents case presentation

I. Severe Hypophosphatemia and Hypocalcemia Following Intravenous Ferric Derisomaltose and Denosumab Administration
Justin Kritzinger, MD
Internal Medicine Resident (PGY2)
McGill University

Educational Objectives:

  1. Calcium and phosphorus homeostasis is tightly regulated via several hormones including PTH, FGF23, and 1,25D 
  2. iFGF23 levels increase following FCM (and possibly repetitive FDM) administration, resulting in increased renal phosphate excretion and decreased 1,25D production 
  3. Severe hypophosphatemia and hypocalcemia with the use of FDM and denosumab, respectively are rare  
  4. Synergistic effects likely exist with concomitant administration that can result in severe electrolyte imbalances 
  5. Routine monitoring and occasional temporary replacement can mitigate the clinical consequences of hypocalcemia and hypophosphatemia

II. Massively Destructive S. Anginosus Endocarditis of a Bicuspid Aortic Valve
Adriano Petrangelo, MD

Internal Medicine Resident (PGY3)
McGill University

Educational Objectives:

  1. Recognize the varied presentations of infective endocarditis
  2. Identify the possible complications of infective endocarditis
  3. Understand predisposing conditions to developing infective endocarditis

III. Crisis in the Cortex
Hajare Iraqi, MD
Internal Medicine Resident (PGY2) 
McGill University

Educational Objectives:

  1. Recognize the clinical presentation of bilateral adrenal hemorrhage.
  2. Identify atypical sites of bleeding complications with direct-acting oral anticoagulants.

March 24

The Osteoporosis Care Gap

I. William Silverstein, MD, MSc FRCPC
Staff Physician, Division of General Internal Medicine,
Sunnybrook Health Sciences Centre
Teachable Moments Editor, JAMA Internal Medicine
Assistant Professor (Clinician in Quality/Innovation),
Department of Medicine and Institute of Health Policy
Management and Evaluation, University of Toronto

II. Steven Shadowitz, MD, MSc, FRCPC
Staff Physician, Division of General Internal Medicine,
Sunnybrook Health Sciences Centre
President, Canadian Society of Internal Medicine
Associate Professor, Department of Medicine,
University of Toronto

Educational Objectives:

  1. Define the osteoporosis care gap
  2. Quantify the incidence and burden of the osteoporosis care gap
  3. Describe a novel approach to improve prescribing rates of anti-osteoporosis treatments after fragility fracture

March 17

Schwartz Rounds
Challenging Interprofessional Conversations

See the  poster
 Zoom link

Louise Miner, MD
Director of Professional Services, JGH

Kevin Hayes
Clinical Ethicist

Vasiliki Bessy Bitzas
Associate Director of Nursing
Palliative Care, JGH

Educational Objectives:

  1. Provide a sense of community
  2. Give voice to healthcare professionals
  3. Normalize compassion for the self and others

March 10

DVT Awareness Month
Antiplatelet + Anticoagulant Therapy: When Less is More

Geoffrey Barnes, MD, MSc
University of Michigan Cardiovascular Center

Educational Objectives:

  1. Select antithrombotic therapies for patients with VTE and acute coronary syndromes that balance thrombosis prevention and bleeding risk
  2. Evaluate the evidence supporting combination anticoagulation-antiplatelet therapy for patients with atrial fibrillation versus VTE

March 3

Advancing Early Diagnosis and Management of Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF): A Path to Better Patient Outcomes

Deborah Assayag, MD
Director, ILD clinic McGill University Health Center
Scientist, Research Institute McGill University Health Center
Associate Professor of Medicine, McGill University

Educational Objectives:  

  1. Recognize the importance of early diagnosis of ILD /IPF
  2. Understand the benefits and limitations of ILD/IPF medications
  3. Develop a practical approach to management of ILD/IPF medications and their side effects

February 24

Thirty Years of BRCA1/2 Research - What Have We Learnt?

William D Foulkes, MD
Division Director of the Divisions of Medical Genetics,
Department of Specialized Medicine, JGH and MUHC
Chair, Dept of Human Genetics, McGill University

Educational Objectives:

  1. To appreciate the advances made, the challenges faced and the road ahead for clinical management of and research into hereditary breast and ovarian cancer.

February 17 – Virtual ONLY

Innovations in Hypertension Control
Remote Management of Hypertension, Renal Denervation, and New Methods of Cuffless BP Monitoring

Naomi D.L. Fisher, MD
Director, Hypertension Service & Hypertension Innovation
Division of Endocrinology, Diabetes and Hypertension
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Educational Objectives:

  1. Implement a process for collecting and reviewing home blood pressure in patients with hypertension, optimizing digital remote methods.
  2. Review evidence for the safety and efficacy of renal denervation, and evaluate patients with uncontrolled hypertension to determine who may benefit from this procedure.
  3. Explain the potential benefits of cuffless BP monitoring.

 

February 10

Hypersensitivity to IV Iron

Jesse Schwartz, MD, MSc, MPH, FRCPC
Chief, Division of Allergy and Clinical Immunology, JGH

Educational Objectives:

  1. Be able to identify and manage hypersensitivity to IV Iron
  2. Develop an approach to hypersensitivity to IV Iron

February 3

Targeted Radionuclide Treatment in Prostate Cancer

Parvaneh Fallah, MD, FRCPC
Medical Oncologist, JGH
Assistant Professor, McGill University

Educational Objectives:

  1. Understand the mechanism of action, available data and recommendations regarding use of targeted Radionuclide treatment in Prostate Cancer
  2. Future directions in using targeted therapy in Oncology

January 27, postponed to February 10

Hypersensitivity to IV Iron

Jesse Schwartz, MD, MSc, MPH, FRCPC
Chief, Division of Allergy and Clinical Immunology
Jewish General Hospital

Educational Objectives:

  1. Be able to identify and manage hypersensitivity to IV Iron
  2. Develop an approach to hypersensitivity to IV Iron

 

January 20

Hybrid Medical Grand Rounds – Residents Case Presentation

The Curious Case of the Man Whose Abdomen Swelled Then Swelled Again

Jack Rudski, MD, CM
PGY-3 Internal Medicine, McGill University
Krish Bilimoria, MD
PGY-3 Internal Medicine, McGill University
David Ji, MD
PGY-3 Internal Medicine, McGill University
Yousef Sebzali, MD
PGY-3 Internal Medicine, McGill University

Educational objectives:

  1. To review an approach to ascites
  2. To diagnose multisystem inflammatory disorders
  3. To maintain strategies to avoid premature diagnostic closure

January 13

Annual Humanization of Care Awareness Program Rounds
Theory to Healing – Bridging Music Therapy and Therapeutic Practice

Patil Harboyan, D.M.A.
Samuel Minevich, M.A., M.T.A.

Educational Objectives:

  1. Understand the principles of music therapy and its role in supporting physical, emotional, and psychological well-being.
  2. Explore evidence-based applications of music therapy in medical settings, including its effects on pain, stress, and rehabilitation.
  3. Recognize how music can be integrated into patient care as part of a holistic approach.

 

December 23

No Rounds – Christmas Day

December 30

No Rounds – New Year’s Day

December 16

Health Equity and Peripheral Artery Disease

Sonia Anand, MD, PhD, FRCPc
Professor, Department of Medicine, McMaster University
Associate Member, Department of Clinical Epidemiology & Biostatistics
Director, Population Genomics Program
Canada Research Chair in Ethnic diversity and Cardiovascular Disease
Heart and Stroke Foundation / Michael G. DeGroote Chair in Population Health Research

Educational Objectives:

  1. Review the pathophysiology of atherothromboembolic disease and its prevalence in diverse populations.
  2. Evaluate clinical trial outcomes, including the efficacy and safety of antithrombotic therapies, with consideration of their applicability to at-risk populations.
  3. Analyze systemic barriers contributing to delays in PAD diagnosis and treatment among marginalized populations
  4. Discuss strategies to optimize PAD management by addressing systemic barriers, promoting equitable access to therapies, and tailoring interventions to improve outcomes

December 9

It’s Not Always About the Arteries!

Jeffrey Minuk, MD
Chief, Division of Neurology, JGH

Educational Objectives:

  1. To review cerebral venous anatomy
  2. To review the clinical features and management of cerebral venous sinus thrombosis

December 2

The Current and Future Role of Cytopathology in Modern Medical Practice

Mauro Saieg, MD, PhD, FIAC
Associate Professor
Department of Pathology 
Jewish General Hospital, McGill University

Educational Objectives:

  1. To understand the scope of diagnosis and organs/systems currently targetable by cytopathology practice
  2. To acknowledge the systems and classification schemes for cytopathology practice
  3. To understand the current role of AI in cytopathological practice and future perspectives of applications

November 25

"Measure Twice Cut Once": Risk Stratification of Thyroid Nodules

Michael Tamilia, MD, FRCPC
Director of Thyroid Center – JGH
Associate Professor of Medicine- McGill University

Educational Objectives:

  1. Elucidate Thyroid investigations.
  2. Explore importance of indeterminants cytology.
  3. Review molecular risk growth for improved stratification.

November 18

Automation and AI in Microbiology: Rise of the Machines

Gerasimos J. Zaharatos, MD, FRCP(C)
Divisions of Infectious Diseases & Medical Microbiology,
Jewish General Hospital
Chief, Division of Medical Microbiology,
Jewish General Hospital & Department of Clinical Laboratory Medicine (Optilab-MUHC)
Associate Professor of Medicine, McGill University

Educational Objectives:

  1. Review the technologic innovations introduced to medical microbiology laboratories in the last decade.
  2. Describe the expected impact of automation and artificial intelligence (AI) on the medical microbiology laboratory.
  3. Explain the potential ramifications of microbiology lab automation and AI on patient care.

November 11

Leading Transformational Change: The Hospital@Home Program

Alla'a Ali, MPH,
Manager of the Virtual Care Transformation Team, DQTEVE&SV

Lawrence Rudski, MD, FRCPC FACC FASE,
Director, Division of Cardiology & Azrieli Heart Center,
Medical Lead of Virtual Care

Erin Cook, MSN,
Director of Quality, Transformation, Evaluation,
Value, Clinical & Organizational Ethics, and Virtual Care 

Educational Objectives:

  1. Understanding the Principles of Change Leadership: Participants will be able to describe the core principles of change leadership and how they can be applied in healthcare
  2. Recognizing the Impact of the Home at Home (H@H) Program: Attendees will explore the outcomes and implications of the H@H program on patient care and healthcare delivery
  3. Learning Change Leadership in Physician Led Interventions: Participants will gain insight into specific interventions that effectively enhance physician participation in the H@H program and their potential impact on program success

November 4

Advances in the Management of Acute Myeloid Leukemia in 2024

Alexandre Bazinet, MDCM, MSc
Assistant Professor, MD Anderson Cancer Center
Houston TX, USA

Educational Objectives:

  1. Understand the molecular heterogeneity of acute myeloid leukemia and how this knowledge is increasingly being used to tailor therapies
  2. Describe the evolution in the treatment of acute myeloid leukemia from a previous “one-size-fits-all” approach to a patient and molecularly-guided approach consisting of chemotherapeutic agents plus targeted agents

October 28

Quality & Risk Management Program

Fostering a Culture of Patient Safety: The Critical Role of Incident Reporting and Incident and Accident Management - Why Everybody’s Involvement Matters

Suzanne Levitz, MD
Associate Director of Professional Services, CCOMTL

Floriane Carole Rukundo, MPH,
Quality, Risk Management and Patient Experience Advisor, CCOMTL

Pierre-Jacques Deblois, MHA,
Quality, Risk Management and Patient Experience Advisor, CCOMTL

Educational Objectives:

  1. To understand the role, importance and requirements of incident and accident reporting in patient safety.
  2. To understand the management and disclosure process of patient safety incidents/accidents.
  3. To promote a culture of accountability, patient safety and continuous quality improvement.

October 21

Resistant Hypertension and the New Kids on the Hypertension Block: Novel Agents with New Mechanisms of Action

Ernesto L. Schiffrin, C.M., MD, PhD, FRSC, FRCPC, FACP
Distinguished James McGill Professor, Department of Medicine, McGill University,
Director, Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research,
Director, Cardiovascular Prevention Centre, Physician-in-Chief Emeritus, JGH

Educational Objectives:

  1. Attendees will learn approaches to resistant hypertension
  2. They will be appraised of the novel drugs for treatment of hypertension that have been developed with new mechanisms of action

October 14

No Rounds – Thanksgiving Day

October 7

Empowering Oncology through Geriatric Expertise: Why Comprehensive Assessments Matter

Professor Pierre Soubeyran, MD, PhD.
Medical Oncologist at Institut Bergonié, Comprehensive Cancer Center,
Professor of Medical Oncology at the University of Bordeaux, France

Miruna Anohim, MD, FRCPC
Geriatric Medicine, Jewish General Hospital     

Erika Martinez B.SC. N CON (C)
Oncology Pivot Nurse – Breast Cancer, Jewish General Hospital

Educational Objectives:

  1. To explore the impact of frailty on cancer outcomes and provide practical tools for frailty screening in oncology
  2. To recognize the benefits of geriatric assessment and interventions in the field of oncology
  3. To compare multidisciplinary models that foster collaboration between oncology and geriatrics

September 30

Thoracic surgery for the internist

Mathieu Rousseau, MD FRCSC
Program Director, Advanced Thoracic and Upper GI Surgical Oncology Fellowship
Assistant Professor of Surgery, McGill University
Attending Surgeon, Division of Thoracic and Upper Gastrointestinal Surgery, McGill University Health Centre

Educational Objectives:

  1. Review the role of thoracic surgical procedures for internal medicine problems
  2. Learn about modern enhanced-recovery principles as applied to thoracic surgical pathologies

September 23

Repurposing Old Drugs for New Indications: The Good, the Bad and the Ugly

Samy Suissa, PhD, FRSC, FCAHS
Distinguished James McGill Professor of Epidemiology,
Biostatistics and Medicine, McGill University
Director, Centre for Clinical Epidemiology
Lady Davis Research Institute - Jewish General Hospital

Educational Objectives:

  1. Review some recent examples: statins, metformin, allopurinol, etc…
  2. Understand time-related biases in observational studies
  3. Introduce novel study designs with applications to drug repurposing

September 16

SIM ONE, DO ONE, TEACH ONE: Balancing Patient Care & Cardiology Training in the Cardiovascular Intensive Care Unit

I. Maria Fadous, MD, MHPE, FRCPC
Assistant Professor of Medicine, McGill University
Medical Director, Simulation - Division of Cardiology, JGH

II. Maude Peretz-Larochelle, MDCM, FRCPC
Assistant Professor of Medicine, McGill University
Co-Program Director, Adult Cardiology Residency Program, McGill University

Educational Objectives:

  1. Understand the role of simulation-based medical education in cardiology
  2. Identify key applications and benefits of simulation-based training
  3. Describe the challenges and limitations in implementing a simulation-based curriculum
  4. Discuss the role of interdisciplinary simulation and its impact on improving collaboration and communication among healthcare teams
  5. Explore future trends and innovations in simulation

Page last updated on 

We always seek feedback to make our site better.